Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Ramm Pharma Corp (RAMMF)

Ramm Pharma Corp (RAMMF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade RAMMF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Most Recent Stories

More News
RAMM Pharma Announces Resignation of Director

TORONTO, Sept. 15, 2021 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or “ RAMM ”) (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical...

RAMMF : 0.0550 (-76.29%)
RAMM.CN : 0.0400 (unch)
RAMM Pharma Corp. Announces Intention to Commence Normal Course Issuer Bid

TORONTO, July 06, 2021 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM") (CSE: RAMM) , announces its intention to commence a normal course...

RAMMF : 0.0550 (-76.29%)
RAMM.CN : 0.0400 (unch)
RAMM Pharma Completes Acquisition of Canapar Corp.

TORONTO, June 15, 2021 (GLOBE NEWSWIRE) -- Further to its news releases dated May 12 and June 14, 2021, RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM ") (CSE:...

RAMMF : 0.0550 (-76.29%)
RAMM.CN : 0.0400 (unch)
Canapar Corp. Receives Shareholder Approval for Business Combination With RAMM Pharma

TORONTO, June 14, 2021 (GLOBE NEWSWIRE) -- Further to its news release dated May 12, 2021, RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM ") (CSE: RAMM), a...

RAMMF : 0.0550 (-76.29%)
RAMM.CN : 0.0400 (unch)
RAMM Pharma to Acquire 100% of Leading Vertically Integrated European Cannabis Company Canapar Corp.

TORONTO, May 12, 2021 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM ") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical...

RAMMF : 0.0550 (-76.29%)
RAMM.CN : 0.0400 (unch)
RIV.TO : 1.50 (-6.25%)
RAMM Pharma Receives Federal Pharmaceutical Approval and Registration of NettaVet™ 10% CBD Formulation, a First for Veterinary Medicine

TORONTO, April 20, 2021 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM") (CSE: RAMM) (OTC: RAMMF) , a leader in plant-derived cannabinoid...

RAMM.CN : 0.0400 (unch)
RAMMF : 0.0550 (-76.29%)
RAMM Pharma Commences Sales of NettaPet™ CBD Enriched Super Premium Quality Dog Food with Strong Pre-Order Demand

TORONTO, April 09, 2021 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM") (CSE: RAMM) (OTC: RAMMF) , a leader in plant-derived cannabinoid...

RAMM.CN : 0.0400 (unch)
RAMMF : 0.0550 (-76.29%)
RAMM Pharma Initiates Clinical Trials of its Proprietary NettaVet™ Cannabinoid Formulation for Multiple Pathologies in Animals

TORONTO, March 25, 2021 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM") (CSE: RAMM) (OTC: RAMMF) , a leader in plant-derived cannabinoid...

RAMM.CN : 0.0400 (unch)
RAMMF : 0.0550 (-76.29%)

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point N/A
1st Resistance Point N/A
Last Price 0.0550
1st Support Level N/A
2nd Support Level N/A
3rd Support Level N/A

See More

52-Week High 0.0550
Fibonacci 61.8% 0.0550
Fibonacci 50% 0.0550
Fibonacci 38.2% 0.0550
Last Price 0.0550
52-Week Low 0.0550

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar